First Time Loading...

Janux Therapeutics Inc
NASDAQ:JANX

Watchlist Manager
Janux Therapeutics Inc Logo
Janux Therapeutics Inc
NASDAQ:JANX
Watchlist
Price: 47.865 USD 1.62% Market Closed
Updated: May 20, 2024

Janux Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Janux Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Janux Therapeutics Inc
NASDAQ:JANX
Cash from Operating Activities
-$50.6m
CAGR 3-Years
-126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.7B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8.5B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.9B
CAGR 3-Years
5%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
24%

See Also

What is Janux Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-50.6m USD

Based on the financial report for Dec 31, 2023, Janux Therapeutics Inc's Cash from Operating Activities amounts to -50.6m USD.

What is Janux Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-126%

Over the last year, the Cash from Operating Activities growth was -18%. The average annual Cash from Operating Activities growth rates for Janux Therapeutics Inc have been -126% over the past three years .